Circulating CD14+HLA‐DRlo/‐ monocytic cells as a biomarker for epithelial ovarian cancer progression

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Circulating CD14+HLA‐DRlo/‐ monocytic cells as a biomarker for epithelial ovarian cancer progression'. Together they form a unique fingerprint.

Medicine & Life Sciences